SCHEMBL2219724

SCHEMBL2219724

CCCCCCCC/C=C\CCCCCCCC(=O)OCN1CCNCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
PRKCE Q02156 1/20 0.48
PRKCQ Q04759 1/20 0.48
PRKCD Q05655 1/20 0.48
PRKCA P17252 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
CNR1 P21554 1/20 0.48
MGLL Q99685 1/20 0.46
FAAH O00519 2/20 0.46
LPAR1 Q92633 5/20 0.45
ENPP2 Q13822 2/20 0.45
LPAR4 Q99677 2/20 0.45
LPAR5 Q9H1C0 2/20 0.45
LPAR2 Q9HBW0 2/20 0.45
LPAR3 Q9UBY5 2/20 0.45
CES2 O00748 1/20 0.45
LPAR6 P43657 1/20 0.45
TRPV1 Q8NER1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263737 1.00 DGKA (0.50) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL2219074 0.92 DGKA (0.51) DGKAALDH1A1MAPT
SCHEMBL2222768 0.92 DGKA (0.51) DGKAALDH1A1MAPT
Hydrochloric Acid SCHEMBL2221631 0.90 GNAI3 (0.52) DGKAALDH1A1MAPT
SCHEMBL29255838 0.88 DGKA (0.53) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL29255816 0.88 DGKA (0.53) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL5874362 0.81 TERT (0.47) DGKAMAPTFAAH
SCHEMBL23372759 0.80 SIGMAR1 (0.40) DGKAALDH1A1
SCHEMBL4264512 0.79 FAAH (0.51) ALDH1A1MAPTTHRBCNR1MGLL
SCHEMBL5874706 0.78 ALDH1A1 (0.51) ALDH1A1MAPTTHRBCNR1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011084849-A1 DIARYLDIAZEPINE PRODRUGS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS ALKERMES, INC. (US) 2011-07-14 WO disclosed
WO-2011084846-A1 QUATERNARY AMMONIUM SALT PRODRUGS ALKERMES, INC. (US) 2011-07-14 WO disclosed